PPL
67
-2
GS
69
-3
IP
62
-2
BMY
35
2
KIM
51
4
AZO
45
2
IRM
71
-2
JPM
71
2
BIIB
45
-3
HES
68
2
LMT
52
2
BEN
41
-9
FOX
50
2
CL
61
-5
CI
49
3
IFF
69
13
MS
70
-2
DG
36
-2
BXP
52
-2
SLB
46
2
PPL
67
-2
GS
69
-3
IP
62
-2
BMY
35
2
KIM
51
4
AZO
45
2
IRM
71
-2
JPM
71
2
BIIB
45
-3
HES
68
2
LMT
52
2
BEN
41
-9
FOX
50
2
CL
61
-5
CI
49
3
IFF
69
13
MS
70
-2
DG
36
-2
BXP
52
-2
SLB
46
2
Financhill
Back

AnaptysBio 10K Form

Buy
55

ANAB
AnaptysBio

Last Price:
25.07
Seasonality Move:
-7.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio Quarterly
2023-08-07 10Q ANAB/AnaptysBio Quarterly
2023-05-11 10Q ANAB/AnaptysBio Quarterly
2022-11-08 10Q ANAB/AnaptysBio Quarterly
2022-08-08 10Q ANAB/AnaptysBio Quarterly
2022-05-04 10Q ANAB/AnaptysBio Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $17.16M
Cash Flow: $-37.28M
Price / Cash Flow: 0
Annual Sales: $1.75
Price / Book: 14.33

Profitability

EPS (TTM): -6.14000
Net Income (TTM): $-163.3M
Gross Margin: $5.48M
Return on Equity: -137.04%
Return on Assets: -33.82%

AnaptysBio Earnings Forecast

Key AnaptysBio Financial Ratios

  • The Gross Profit Margin over the past 1 years for ANAB is 100.00%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 244.48% of Gross Profit Margin.
  • The Research & Development expenses have been 771.01% of Revenue.
  • The Interest Expense is -11.05% of Operating Income.
  • The Net Earning history of ANAB is -953.66% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

AnaptysBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 11.53
Quick Ratio: 11.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Buy
55
AnaptysBio (ANAB) is a Buy

Is AnaptysBio a Buy or a Sell?

  • AnaptysBio stock is rated a Buy
    The current AnaptysBio [ANAB] share price is $25.07. The Score for ANAB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.